BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29698714)

  • 1. pH-responsive delivery of Griffithsin from electrospun fibers.
    Tyo KM; Duan J; Kollipara P; Dela Cerna MVC; Lee D; Palmer KE; Steinbach-Rankins JM
    Eur J Pharm Biopharm; 2019 May; 138():64-74. PubMed ID: 29698714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
    Grooms TN; Vuong HR; Tyo KM; Malik DA; Sims LB; Whittington CP; Palmer KE; Matoba N; Steinbach-Rankins JM
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6518-6531. PubMed ID: 27550363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections.
    Tyo KM; Lasnik AB; Zhang L; Jenson AB; Fuqua JL; Palmer KE; Steinbach-Rankins JM
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
    Minooei F; Fried JR; Fuqua JL; Palmer KE; Steinbach-Rankins JM
    Int J Nanomedicine; 2021; 16():1189-1206. PubMed ID: 33623382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.
    Tyo KM; Lasnik AB; Zhang L; Mahmoud M; Jenson AB; Fuqua JL; Palmer KE; Steinbach-Rankins JM
    J Control Release; 2020 May; 321():84-99. PubMed ID: 32035194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
    Tyo KM; Vuong HR; Malik DA; Sims LB; Alatassi H; Duan J; Watson WH; Steinbach-Rankins JM
    Int J Pharm; 2017 Oct; 531(1):118-133. PubMed ID: 28797967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.
    Aniagyei SE; Sims LB; Malik DA; Tyo KM; Curry KC; Kim W; Hodge DA; Duan J; Steinbach-Rankins JM
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():238-251. PubMed ID: 28024582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.
    Vuong HR; Tyo KM; Steinbach-Rankins JM
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.
    Halwes ME; Tyo KM; Steinbach-Rankins JM; Frieboes HB
    Mol Pharm; 2018 Apr; 15(4):1534-1547. PubMed ID: 29481088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
    Kramzer LF; Hamorsky KT; Graebing PW; Wang L; Fuqua JL; Matoba N; Lasnik AB; Moncla BJ; Zhang J; Palmer KE; Rohan LC
    AAPS PharmSciTech; 2021 Feb; 22(3):83. PubMed ID: 33625602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
    Emau P; Tian B; O'keefe BR; Mori T; McMahon JB; Palmer KE; Jiang Y; Bekele G; Tsai CC
    J Med Primatol; 2007 Aug; 36(4-5):244-53. PubMed ID: 17669213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Poly(lactic-
    Yang H; Li J; Patel SK; Palmer KE; Devlin B; Rohan LC
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30995761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis.
    Nabeta HW; Lasnik AB; Fuqua JL; Wang L; Rohan LC; Palmer KE
    Front Cell Infect Microbiol; 2022; 12():976033. PubMed ID: 36329822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
    Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antiviral activity of the microbicide candidate griffithsin and its tandemers derivatives against different modes of HIV-1 transmission.
    Alexandre K; Malatji K; Mulaudzi T
    Virology; 2020 May; 544():12-20. PubMed ID: 32174510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.
    Derby N; Lal M; Aravantinou M; Kizima L; Barnable P; Rodriguez A; Lai M; Wesenberg A; Ugaonkar S; Levendosky K; Mizenina O; Kleinbeck K; Lifson JD; Peet MM; Lloyd Z; Benson M; Heneine W; O'Keefe BR; Robbiani M; Martinelli E; Grasperge B; Blanchard J; Gettie A; Teleshova N; Fernández-Romero JA; Zydowsky TM
    Nat Commun; 2018 Sep; 9(1):3881. PubMed ID: 30250170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines.
    Kim S; Traore YL; Ho EA; Shafiq M; Kim SH; Liu S
    Acta Biomater; 2018 Dec; 82():12-23. PubMed ID: 30296620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide.
    Qiu M; Chen Y; Song S; Song H; Chu Y; Yuan Z; Cheng L; Zheng D; Chen Z; Wu Z
    Antiviral Res; 2012 Nov; 96(2):138-47. PubMed ID: 22940611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.
    Lal M; Lai M; Ugaonkar S; Wesenberg A; Kizima L; Rodriguez A; Levendosky K; Mizenina O; Fernández-Romero J; Zydowsky T
    J Pharm Sci; 2018 Oct; 107(10):2601-2610. PubMed ID: 29902477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.